Skip to main content
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
S&P 500 5,142.30 +0.87%|NASDAQ 16,284.75 +1.12%|DOW 38,972.10 -0.23%|AAPL $192.45 +1.80%|TSLA $241.80 -2.10%|AMZN $178.92 +0.54%|GOOGL $141.20 +0.32%|MSFT $415.60 -0.15%|
As of Mar 30
HealthUnited States3 sourcesNeutral

Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis

Significant improvements in pain, function and patient global outcomes demonstratedLEVI-04 well tolerated and exhibits

Norfolk Daily News
via Norfolk Daily News - Corroborated by 2 others

Source Verification

Corroboration Score: 3

This story was independently reported by 3 sources. Click any source to read the original article.

Comments

0 comments
Be respectful and constructive.
Loading comments...